Obstetric outcome in systemic lupus erythematosus

• Published in: Seminars in arthritis and rheumatism Vol. 25; no. 3; pp. 184 - 192
• Main Authors: Lima, Fernanda, Buchanan, Neil M.M., Khamashta, Munther A., Kerslake, Siân, Hughes, Graham R.V.
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA Elsevier Inc 01.12.1995; Elsevier
• Subjects: Adult; Antibodies, Antiphospholipid - immunology; Biological and medical sciences; Diseases of mother, fetus and pregnancy; Female; Fetal Death - etiology; Gynecology. Andrology. Obstetrics; Humans; Lupus Erythematosus, Systemic - complications; Lupus Erythematosus, Systemic - therapy; Medical sciences; Pregnancy; Pregnancy Complications - immunology; Pregnancy Complications - therapy; Pregnancy Outcome; Pregnancy. Fetus. Placenta; APS; NND; PROM; pregnancy; fetal loss; aCL; NNL; antiphospholipid antibodies; Systemic lupus erythematosus; PNP; TOP; IUGR; LA; CTG; IUD; aPL; CHB; FD; WHO; Human; Immunopathology; Connective tissue disease; Skin disease; Prognosis; Pregnancy disorders; Antiinflammatory agent; Autoimmune disease; Pregnancy; Immunomodulator; Chemotherapy; Newborn; Treatment; Systemic disease; Evolution; Female; Fetus; Lupus erythematosus; Disseminated

A prospective study was performed to investigate the fetal and maternal outcome of 108 pregnancies in 90 lupus patients. The protocol was based on shared care of the patients by a rheumatologist and an obstetrician, with input from a hematologist, if necessary. Lupus flares were treated with low-dos...